Source: Biomedicine and Pharmacotherapy. Unidades: IDPC, IME, FCF
Subjects: BIOMARCADORES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Mariana Vieira de Mello Barros et al. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease?. Biomedicine and Pharmacotherapy, v. 160, p. 1-12 art. 114345, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2023.114345. Acesso em: 19 ago. 2024.APA
Pimentel, M. V. de M. B., Bertolami, A., Fernandes, L. P., Barroso, L. P., & Castro, I. A. de. (2023). Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? Biomedicine and Pharmacotherapy, 160, 1-12 art. 114345. doi:10.1016/j.biopha.2023.114345NLM
Pimentel MV de MB, Bertolami A, Fernandes LP, Barroso LP, Castro IA de. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? [Internet]. Biomedicine and Pharmacotherapy. 2023 ; 160 1-12 art. 114345.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.biopha.2023.114345Vancouver
Pimentel MV de MB, Bertolami A, Fernandes LP, Barroso LP, Castro IA de. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? [Internet]. Biomedicine and Pharmacotherapy. 2023 ; 160 1-12 art. 114345.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.biopha.2023.114345